Skip to content

Insider · CIK 0001559570

David Shapiro

director

Files at DMRA (Damora Therapeutics, Inc.), DSGN (Design Therapeutics, Inc.). First filing -, latest -.

David Shapiro files SEC Form 4 as director at DMRA (Damora Therapeutics, Inc.), and also at DSGN (Design Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; David Shapiro has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 9, 2026DSGN
Design Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+30,000$0.00$030,000Jun 11, 2026
Mar 31, 2026DSGN
Design Therapeutics, Inc.
AGrant or award
Stock option (right to buy)derivative
+60,000$0.00$060,000Apr 1, 2026
Mar 31, 2026DSGN
Design Therapeutics, Inc.
AGrant or award
Stock option (right to buy)derivative
+7,500$0.00$07,500Apr 1, 2026
Jun 18, 2025DMRA
Damora Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+720$0.00$0720Jun 20, 2025

Questions about David Shapiro

Answered from the filings on this page, as of the latest one.

Is David Shapiro buying or selling?

David Shapiro has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did David Shapiro's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Shapiro has 0.

Where does David Shapiro file Form 4?

David Shapiro has filed Form 4 at DMRA (Damora Therapeutics, Inc.); DSGN (Design Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David Shapiro: insider trades and track record | InsiderTell